[Skip to Content Landing] Original Investigation November 13, 2020 JAMA. 2020;324(23):2406-2414. doi:10.1001/jama.2020.22708 JAMA Insights Fractional Flow Reserve Measurement for Assessing Coronary Artery Stenosis Deepak L. Bhatt, MD, MPH Brief Report Improvement in Fractional Flow Reserve and Outcomes After Percutaneous Coronary Intervention Stephane Fournier, MD; Giovanni Ciccarelli, MD; Gabor G. Toth, MD, PhD; Anastasios Milkas, MD; Panagiotis Xaplanteris, MD, PhD; Pim A. L.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Maria Koh
Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention
Journal of the American College of Cardiology Original Investigation Maneesh Sud, Lu Han, Maria Koh, Husam Abdel-Qadir, Peter C. Austin, Michael E. Farkouh, Lucas C. Godoy, Patrick R. Lawler, Jacob A. Udell, Harindra C. Wijeysundera and Dennis T. Ko This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click the login link or the subscribe link in the top menu above to access this article.
Clinical Outcomes With Beta-Blocker Use in Patients With Recent History of Myocardial Infarction
Abstract Background It is uncertain whether beta-blockers (BBs) are beneficial in contemporary stable patients with prior myocardial infarction (MI). Therefore, we sought to examine the effectiveness of BB use in this population. Methods We conducted a cohort study with the use of administrative databases of patients ≥ 65 years of age, alive on April 1, 2012 (index date) with a hospital discharge diagnosis of MI within the previous 3 years.
Association Between Hospital Teaching Status and Outcomes After Out-of-Hospital Cardiac Arrest
Andrew Czarnecki Andrew Czarnecki Andrew Czarnecki, MD, MSc, Sunnybrook Health Sciences Centre, D-375, 2075 Bayview Ave, Toronto, Ontario, M4N 3M5. Email Schulich Heart Centre (A.C., D.T.K.), Sunnybrook Health Sciences Centre, Toronto, ON, Canada. Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada (A.C., F.Q., M.K., D.C.S., D.T.K.). Department of Medicine (A.C., S.C., P.D., D.C.S., D.T.K.), University of Toronto, ON, Canada.
Field Implementation of Remote Ischemic Conditioning in ST-elevation Myocardial Infarction: The FIRST study
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 Consort diagram of patient population in pre-implementation and post implementation phases of study.
Population Impact of Generic Valsartan Recall
Originally published11 Nov 2019https://doi.org/10.1161/CIRCULATIONAHA.119.044494Circulation. ;0:null Abstract On July 9, 2018, Health Canada announced a voluntary recall of 6 generic valsartan products due to the detection of a known carcinogen nitrosodimethylamine (NDMA).1 In total, more than 22 countries, including the United States, initiated recalls.
Training/Practice: Health Policy and Promotion The risk of cardiovascular events on cannabis’ highest day
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 Legend: The incidence of ED visits per 1,000,000 Ontarians due to any cardiovascular diagnosis was determined for each “4/20” day between 2008 and 2017. The incident rate ratio (IRR) was determined by comparing the rate of events on “4/20” to the mean of events occurring 1-week prior and 1-week subsequent to “4/20”.
Risk of cardiac events during the Super Bowl
Triggering of acute myocardial infarction onset by episodes of anger Delays in seeking medical care in hospitalized patients with decompensated heart failure Brunner, S, Herbel, R, Drobesch, C Alcohol consumption, sinus tachycardia, and cardiac arrhythmia at the Munich Octoberfest: results from the Munich Beer Related Electrocardiogram Workup Study (MunichBREW) . Eur Heart J ; 38: – .
Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00 Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome
Background Although generic medications are approved based on bioequivalence with brand‐name medications, there remains substantial concern regarding their clinical effectiveness and safety. Lipitor ® , available as generic atorvastatin, is one of the most commonly prescribed statins. Therefore, we compared the effectiveness of generic atorvastatin products and Lipitor ® .
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Maria
Contact Maria, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack